European Agency: Adapting vaccines to the new Corona mutant is premature

The Hague-Sana

The European Medicines Agency announced today that it is too early to plan to adapt vaccines to the new mutated coronavirus discovered in South Africa.

"It is premature at the present time to think about adapting vaccines in order to combat this new mutant called B.1.1.529, which was detected in South Africa with many copies of it," alerting the possibility that this new strain is severe, the agency quoted the agency as saying. Infection according to South African scientists.

European and Asian countries have tightened travel restrictions to their lands, after a new mutated strain of the Corona virus was detected in South Africa, and an infection with this mutant was recorded in Belgium.